POSTER SESSION IV
Tuesday, March 4, 2008 — 1:00 PM - 4:30 PM
Convention Center Exhibit Hall A
Click on the blue numbers in parentheses to display abstracts.
Click the button next to any title to add to Itinerary Planner...
PULMONARY PATHOLOGY
Poster#
Title and Authors
Itinerary Planner
148
Clinical Significance of TTF-1 Protein Expression and TTF-1 Gene Amplification in Lung Adenocarcinoma
(1532)
JA Barletta, BA Weir, S Perner, L Johnson, MA Rubin, BE Johnson, M Meyerson, LR Chirieac - Brigham and Women's Hospital, Boston, MA; Dana-Farber Cancer Institute, Boston, MA
Combined Small Cell Carcinomas: Loss-of-Heterozygosity and Immunohistochemical Analysis of the Individual Components
(1607)
PL Wagner, Y-T Chen, MF Vazquez, A Saqi - Weill Medical College of Cornell University, New York, NY
Expression of Inhibin-alpha in Non-Small Cell Carcinoma of the Lung with a Focus on Adenocarcinoma - A Diagnostic Pitfall in the Evaluation of Metastatic Pulmonary Carcinoma
(1611)
K Zhang, J Shi, F Lin - Geisinger Health System, Danville, PA
Expression of Inhibin-alpha in Primary Pulmonary Non-Small Cell Carcinomas by Immunohistochemistry
(1605)
DY Tigrani, JA Weydert - University of Iowa, Iowa City, IA
Utility of S100P in Differentiating Adenocarcinoma of the Lung from Papillary Carcinoma and Follicular Carcinoma of the Thyroid
(1551)
P Dorion, J Shi, K Zhang, C Schuerch, F Lin - Geisinger Medical Center, Danville, PA
Stem Cell Marker Expression in Pulmonary Carcinomas Is Associated with Histological Type and Differentiation
(1586)
AL Moreira, M Moore, T Akhurst, RJ Downey - Memorial Sloan Kettering Cancer Center, New York, NY; MSKCC, NY, NY
Overexpression of NRF2 Is Correlated with Elevated p53 Levels in Pulmonary Papillary Adenocarcinoma by Tissue Microarray Analysis
(1575)
QK Li, E Tully, FB Askin, E Gabrielson - Johns Hopkins Hospitals, Baltimore, MD
RON Overexpression and Activation in Primary and Metastatic Lung Carcinoma
(1578)
A Malik, S Krishnaswamy, C Gong, AN Husain, R Salgia, M Tretiakova - University of Chicago, Chicago, IL
Tumor Anaplastic Lymphoma Kinase Expression among Patients with Non-Small Cell Carcinoma of the Lung
(1537)
JM Boland, S Erdogan, G Vasmatzis, P Yang, LS Tillmans, MC Aubry, ES Yi - Mayo Clinic, Rochester, MN
Presence of Alveolar Macrophages Correlates with Lower Stage and Increased Survival in Non-Small Cell Lung Carcinoma
(1595)
A Saqi, P Wagner, N Altorki, P Lee, S Paul, J Port, M Vazquez - Weill Medical College of Cornell University, New York, NY; New York Hospital/Weill Cornell Medical Center, New York, NY
Alpha-methylacyl-co-a-racemase Expression Is a Biomarker of Poor Prognosis in Stage 1 and 2 Large Cell Carcinomas of the Lung
(1572)
UR Kundu, W Li, D Tan, TC Allen, QJ Zhai, PT Cagle - University of Texas, Houston; MD Anderson Cancer Center, Houston; University of Texas, Tyler; Methodist Hospital/Weill College of Medicine Cornell University, Houston
ProEx C Expression in Non-Small Cell Lung Cancers Is Associated with Longer Patient Survival
(1597)
M Shahjahan, QJ Zhai, TC Allen, AE Sienko, A Haque, R Barrios, S Chakraborty, DR Mody, PT Cagle - The Methodist Hospital, Houston, TX; The University of Texas Health Center at Tyler, Tyler, TX
Expression of Galectin-4 in Non-Small Cell Lung Carcinoma and Correlation with Survival
(1602)
AE Sienko, TC Allen, R Barrios, S Chakraborty, PT Cagle - Weill College of Medicine Cornell University, Houston, TX; University of Texas Health Center, Tyler, TX
Immunohistochemical Expression of Signaling Molecules Erb-B3, MKP-3, and Stat1 in Non-Small Cell Lung Carcinoma
(1571)
SM Kulich, PT Cagle, EM Cozza, SR Land, D Lenzner, L Brcic, S Dacic - VA Pittsburgh Healthcare System, Pittsburgh; University of Pittsburgh Medical Center, Pittsburgh; The Methodist Hospital, Houston; University of Pittsburgh Graduate School of Public Health, Pittsburgh; University of Zagreb School of Medicine, Zagreb, Croatia
Expression of Phosphorylated AKT in Non Small Cell Lung Cancers
(1567)
SM Homan, RA Patel, CE Sheehan, JS Ross, TA Jennings - Albany Medical College, Albany, NY
Prognostic Value of Aspartyl (Asparaginyl) b- Hydroxylase in Lung Carcinomas: Correlation with Survival
(1577)
M Luu, E Sabo, M Resnick, W Greaves, S de la Monte, JY Wang, R Tavares, L Simao, J Wands, LJ Wang - Rhode Island Hospital; Liver Research Center and The Warren Alpert Medical School of Brown University, Providence, RI
Tissue Microarray Study of RNA-Binding Protein IMP3 in Primary Non-Small Cell Lung Cancers: Prediction of Survival in Early Stage Squamous Cell Carcinomas
(1606)
P Vohra, PT Cagle, TC Allen, K Dresser, S Chakraborty, AE Fraire - University of Massachusetts Medical School, Worcester, MA; The Methodist Hospital, Houston, TX; University of Texas Health Center, Tyler, TX
Stage I Adenocarcinomas of the Lung: A Single Institution Study of 287 Patients Evaluating the Relationship of Histopathologic Subtypes and Tumor Recurrence
(1531)
AV Arrossi, S Reznik, S Murthy, E Blackstone, CF Farver - The Cleveland Clinic Foundation, Cleveland, OH
The Role of Molecular Analysis in Differentiating Invasive Adenocarcinoma of the Lung with a Predominant Lepidic, Bronchioalveolar Pattern from a Bronchioloalveolar Carcinoma with Focal Invasion
(1584)
A Mohanty, SD Finkelstein, TC Pereira, JF Silverman - Allegheny General Hospital, Pittsburgh, PA; RedPath Integrated Pathology Inc, Pittsburgh, PA
Nuclear Localization of Maspin Is Associated with an Increased Response Rate and Favorable Pathological Features in Resected Lung Adenocarcinoma and, in Stage I, Constitutes an Independent Predictor of Improved Survival
(1557)
AB Frey, S Sheng, H Pass, F Lonardo - Wayne State University, Harper Hospital and The Karmanos Cancer Institute, Detroit, MI; New York University, New York, NY
TTF1 Amplification Defines TTF1 Overexpression in Lung Adenocarcinomas
(1590)
S Perner, F Demichelis, L Johnson, B Weir, J Barletta, M Meyerson, L Chireac, MA Rubin - Brigham and Women's Hospital, Boston, MA; The Broad Institute of Harvard and MIT, Cambridge, MA
Epidermal Growth Factor Receptor Expression and Gene Amplification in Non-Small-Cell Lung Carcinomas: Correlation between Gene Copy Number and Protein Expression
(1574)
HJ Lee, JH Chung, G Choe, S Jheon, SW Sung, CT Lee - Seoul National University College of Medicine, Seoul National University Bundang Hospital, Seongnam, Gyeonggi-do, Republic of Korea
Genotype-Phenotype Correlation in Non-Small Cell Lung Carcinoma
(1599)
LM Sholl, AJ Iafrate, B Yeap, A Holmes, Y Chou, M Wu, Y Goan, L Su, PA Jänne, DC Christiani, LR Chirieac - Brigham and Women's Hospital, Boston; Massachusetts General Hospital, Boston; Kaohsiung Veteran General Hospital, Kaohsiung, Taiwan; Dana Farber Cancer Institute, Boston; Harvard School of Public Health, Boston
Mutation and Intron 1 Polymorphism of the Epidermal Growth Factor Receptor, and Its Relationship with Gefitinib Sensitivity in Korean Patients with Non-Small Cell Lung Cancer
(1570)
MJ Kim, SH Seok, KC Shin, KH Lee - Yeungnam University Hospital, Daegu, Republic of Korea
Evidence Based Pathology: Are EGFR Tests Valid Predictors of Treatment Response to Erlotinib or Gefitinib in Patients with Pulmonary Adenocarcinoma?
(1548)
AM Dastane, R Gupta, RJ Mckenna, A Marchevsky - Cedars Sinai Medical Center, LA, CA
button next to any title to add to Itinerary Planner...
Add
